Literature DB >> 1422823

5-Hydroxytryptamine-3 receptors modulate synaptic activity in the rat nucleus tractus solitarius in vitro.

S R Glaum1, P A Brooks, K M Spyer, R J Miller.   

Abstract

Whole-cell patch clamp recordings were made from neurons in the rat nucleus tractus solitarius (NTS) in transverse brainstem slices. 5-Hydroxytryptamine (5-HT, 100 microM) and the selective 5-HT3 receptor agonist 2-methyl-5-HT (2-CH3-5-HT, 100 microM) depolarized 86% of NTS neurons at resting membrane potential (Vm). This response was resistant to tetrodotoxin (TTX) and Co2+ application. In addition, 2-CH3-5-HT (500 nM-100 microM) increased the amplitude and frequency of both excitatory and inhibitory spontaneous synaptic potentials. This effect was also TTX-resistant, but was abolished by Co2+. The effects of 2-CH3-5-HT on EPSPs and IPSPs evoked by electrical stimulation of the tractus solitarius (TS) were analyzed separately in the presence of bicuculline or 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), respectively. Concentrations of 2-CH3-5-HT between 500 nM and 1 microM decreased the amplitude of evoked EPSPs and IPSPs with similar potency. The selective 5-HT3 receptor antagonists ICS 205-930 (10 nM) and MDL 72222 (10 microM) reversibly blocked the effects of 2-CH3-5-HT at all doses examined. It is concluded that 5-HT3 receptors can mediate both pre- and postsynaptic responses in the NTS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422823     DOI: 10.1016/0006-8993(92)91162-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  Non-NMDA receptors transmit cardiopulmonary C fibre input in nucleus tractus solitarii in rats.

Authors:  C G Wilson; Z Zhang; A C Bonham
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

2.  Glucose increases synaptic transmission from vagal afferent central nerve terminals via modulation of 5-HT3 receptors.

Authors:  Shuxia Wan; Kirsteen N Browning
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-18       Impact factor: 4.052

3.  Presynaptic 5-HT3 receptors evoke an excitatory response in dorsal vagal preganglionic neurones in anaesthetized rats.

Authors:  Y Wang; A G Ramage; D Jordan
Journal:  J Physiol       Date:  1998-06-15       Impact factor: 5.182

4.  The effect of 5-HT and selective 5-HT receptor agonists and antagonists on rat dorsal vagal preganglionic neurones in vitro.

Authors:  A P Albert; K M Spyer; P A Brooks
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 5.  Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.

Authors:  Tina K Machu
Journal:  Pharmacol Ther       Date:  2011-02-26       Impact factor: 12.310

6.  Effects of acute and chronic nicotine on catecholamine neurons of the nucleus of the solitary tract.

Authors:  Stephen J Page; Mingyan Zhu; Suzanne M Appleyard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-10-24       Impact factor: 3.619

7.  Serotonin activates catecholamine neurons in the solitary tract nucleus by increasing spontaneous glutamate inputs.

Authors:  Ran Ji Cui; Brandon L Roberts; Huan Zhao; Mingyan Zhu; Suzanne M Appleyard
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

8.  An electrophysiological investigation of the properties of 5-HT3 receptors of rabbit nodose ganglion neurones in culture.

Authors:  J A Peters; H M Malone; J J Lambert
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

Review 9.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

10.  Mediation by 5-HT3 receptors of an excitatory effect of 5-HT on dorsal vagal preganglionic neurones in anaesthetized rats: an ionophoretic study.

Authors:  Y Wang; A G Ramage; D Jordan
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.